Increasing Placebo Response Rates and the Threat to Clinical Trials: How Will We Identify Effective Treatments for Rheumatic Disorders?

Matthew J. Parkes
, David T. Felson
, Michael P. LaValley

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	1-3
Journal	Arthritis & Rheumatology
Volume	78
Issue number	1
Early online date	30 Jun 2025
DOIs	https://doi.org/10.1002/art.43303
Publication status	Published - 29 Jan 2026

Access to Document

10.1002/art.43303

Cite this

@article{dc9a5962fae94005943a2cc7278876d4,

title = "Increasing Placebo Response Rates and the Threat to Clinical Trials: How Will We Identify Effective Treatments for Rheumatic Disorders?",

author = "Parkes, \{Matthew J.\} and Felson, \{David T.\} and LaValley, \{Michael P.\}",

year = "2026",

month = jan,

day = "29",

doi = "10.1002/art.43303",

language = "English",

volume = "78",

pages = "1--3",

journal = "Arthritis \& Rheumatology",

issn = "2326-5191",

publisher = "John Wiley \& Sons Ltd",

number = "1",

}

TY - JOUR

T1 - Increasing Placebo Response Rates and the Threat to Clinical Trials: How Will We Identify Effective Treatments for Rheumatic Disorders?

AU - Parkes, Matthew J.

AU - Felson, David T.

AU - LaValley, Michael P.

PY - 2026/1/29

Y1 - 2026/1/29

U2 - 10.1002/art.43303

DO - 10.1002/art.43303

M3 - Editorial

SN - 2326-5191

VL - 78

SP - 1

EP - 3

JO - Arthritis & Rheumatology

JF - Arthritis & Rheumatology

IS - 1

ER -